What is King Pharmaceuticals's international — year 8?

King Pharmaceuticals (KG) reported international — year 8 of -0.1% in Q4 2025.

What does international — year 8 mean?

Represents the financial performance and operational results of the International insurance product line during the eighth year of the reporting cycle. This metric highlights the long-term sustainability of the international business model and its impact on capital allocation. It assists investors in identifying cyclical trends within the global insurance portfolio.

King Pharmaceuticals KG International — Year 8

Other product segments

General Liability

6.4%—

European Hospital Liability

5%—

Commercial Auto Liability

2.3%—

All other lines

0.1%—

Similar metrics at other companies

CNAInternational — Year 8

2.6%—

CNAInternational — Year 10

1.3%—

CNAInternational — Year 7

5.6%—

CNAInternational — Year 9

2.8%—

GLREHealth — Year 8

0%—

ESN

ESNTProperty Insurance Product Line — Year 8

0%—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's international — year 8.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's international — year 8?: King Pharmaceuticals (KG) reported international — year 8 of -0.1% in Q4 2025.
What does international — year 8 mean?: Represents the financial performance and operational results of the International insurance product line during the eighth year of the reporting cycle. This metric highlights the long-term sustainability of the international business model and its impact on capital allocation. It assists investors in identifying cyclical trends within the global insurance portfolio.